The "Cell and Gene Supply Chain" refers to the network of processes and establishments involved in the development, manufacturing, distribution, and storage of cellular and gene-based medicines. A few of the stages involved in this complex system are the acquisition of raw materials, gene or cell manipulation, quality control, shipping, and patient administration. Ensuring the safety and integrity of these innovative therapies along the whole supply chain is crucial in order to provide patients with reliable, efficient, and consistent care.